GlassScriptPhysician profile
Deidra M Casaus
NPI 1609889310
$4,452.63
in general payments reported to CMS, 2019-2025
16 companies · $970 in 2025
The $970 reported for 2025 was more than what 90% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $689 · 2020: $239 · 2021: $463 · 2022: $772 · 2023: $653 · 2024: $667 · 2025: $970.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,078 · Entertainment: $212.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,078.17 |
| Entertainment | $211.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $1,020.44 | 2022-2025 | Infuse, Biotrue One Day |
| Coopervision INC. | $964.75 | 2019-2025 | Myday Contact Lens, Misight Contact Lens, Clariti Contact Lens |
| Alcon Vision LLC | $543.95 | 2020-2025 | Precision7, Total30 |
| Optos, INC. | $464.96 | 2020-2024 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $392.41 | 2019-2021 | |
| Dompe US, INC. | $188.10 | 2025 | Oxervate |
| Sight Sciences, INC. | $156.69 | 2022-2023 | Tearcare System |
| Lumenis Be INC | $145.04 | 2024 | Optilight |
| Allergan, INC. | $128.72 | 2022 | |
| Abb Con-Cise Optical Group LLC | $106.58 | 2021 | |
| Carl Zeiss Meditec, INC. | $92.34 | 2019-2020 | |
| Genzyme Corporation | $89.49 | 2019 | |
| Shire North American Group INC | $79.06 | 2019 | |
| Maculogix, INC. | $33.01 | 2019-2020 | |
| Biotissue Holdings INC. | $29.18 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $17.91 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Deidra Casaus listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.